Mifepristone Amicus Brief: Alliance for Hippocratic Medicine v. U.S. Food and Drug AdministrationFebruary 2, 2024
Advancing Justice - AAJC and NAPAWF filed an amicus brief urging Supreme Court to protect access to medication abortion the U.S.
Asian Americans Advancing Justice - Asian American Justice Center (Advancing Justice - AAJC) and the National Asian Pacific American Women’s Forum (NAPAWF) filed an amicus brief on behalf of themselves and AAPI, Black, Latina, and immigrant women’s organizations urging the U.S. Supreme Court to protect access to medication abortion.
In the case Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, the justices are deciding whether to overturn or restrict FDA approval of mifepristone, one of the pills commonly used in medication abortion. The brief filed jointly by Advancing Justice – AAJC and NAPAWF explains that for many women of color, medication abortion is the only abortion care to which they have access. The brief further underscores the medical, social, and personal importance of medication abortion to women of color, and that if the Supreme Court ruling requires in-person dispensing of the product, that access to critical abortion care for women of color will be severely threatened.